Jupiter Neurosciences, Inc.

Healthcare · Biotechnology · United States

Last price 2.37 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.12M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson’s disease; JNS108, which is in Phase II clinical trial for the treatment of mild cognitive impairment/early Alz...